Answers are grounded in this paper and cite their sources.
Qualitative study reveals young adult cancer survivors rely on informal sources for medical cannabis due to provider hesitancy, highlighting the need for evidence-based clinical guidance.
BACKGROUND: Given the increasing prevalence of young adult (YA) cannabis use and medical cannabis (MC) use, which is particularly relevant to cancer-related symptoms, we examined MC use and related factors among YA cancer survivors (ages 18-39). METHODS: = 1.22 ± 1.09 years post-treatment), assessing: implications of cannabis legalization, MC information sources, healthcare provider interactions, and symptoms/conditions MC managed. Data were analyzed using thematic analysis. RESULTS: During treatment, 56.5% lived in states with MC-only legal and 34.8% fully legal cannabis; at time of interview, 21.7% lived in states with MC-only and 73.9% fully legal. Themes included: (1) importance of legal context in facilitating or impeding MC access/use; (2) reliance on dispensaries, social networks, and personal research/experimentation for MC information; (3) varied experiences communicating with healthcare providers (little communication, provider hesitancy, providers supporting MC use, contradictory information, stigma-related concerns, desiring shared healthcare decision-making); (4) conditions/symptoms managed and effectiveness; (5) hopes future healthcare better incorporates MC; and (6) concerns/cautions about MC use vs. alternatives. CONCLUSIONS: Findings highlight MC's perceived utility in managing symptoms among YA cancer survivors, alongside fragmented policies/systems impeding evidence-based information or healthcare provider input.
No takes yet. Share an insight, caveat, or question.
Berg et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: